Publication | Closed Access

Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models

HypertensionMedicineAntihypertensive TherapyPhysiologyDiabetesCardiovascular PharmacologyVascular BiologyPharmacotherapyRenoprotective EffectsDog ModelsReceptor BlockerPharmacology